$19.21
+0.47 (+2.51%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-11.52%
1Y
+115.36%
YTD
-7.73%
Open$18.94
Previous Close$18.74
Day High$19.53
Day Low$18.94
52W High$27.65
52W Low$7.96
Volume—
Avg Volume1.48M
Market Cap2.12B
P/E Ratio—
EPS$-2.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.49
Below
SMA 200
$14.32
Above
RSI (14)
37.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+584.5% upside
Current
$19.21
$19.21
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.00M | 603.96M | 550.96M |
| Net Income | -275,368,322 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,060.0% | -28.7% | -29.6% |
| EBITDA | -287,361,538 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |